Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative

Author： Shibata T.   Matsui K.   Nagao K.   Shinkai H.   Yonemori F.   Wakitani K.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.364, Iss.2, 1999-01, pp. : 211-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Triglyceride-lowering effect of a novel insulin-sensitizing agent, JTT-501

By Shibata T.   Matsui K.   Yonemori F.   Wakitani K.  

European Journal of Pharmacology, Vol. 373, Iss. 1, 1999-05 ,pp. : 85-91

Elsevier

Access to resources Recommend Favorite

Glucose-dependent insulinotropic effects of JTT-608, a novel antidiabetic compound

By Furukawa N.   Ohta T.   Noguchi T.   Yonemori F.   Wakitani K.  

European Journal of Pharmacology, Vol. 371, Iss. 1, 1999-04 ,pp. : 51-58

Elsevier

Access to resources Recommend Favorite

Antidiabetic effect of chronic administration of JTT-608, a new hypoglycemic agent, in diabetic Goto-Kakizaki rats

By Ohta T.   Miyajima K.   Komuro G.   Furukawa N.   Yonemori F.  

European Journal of Pharmacology, Vol. 476, Iss. 1, 2003-08 ,pp. : 159-166

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of ramosetron, a novel therapeutic agent for IBS

By Hirata T.   Funatsu T.   Keto Y.   Nakata M.   Sasamata M.  

Inflammopharmacology, Vol. 15, Iss. 1, 2007-02 ,pp. : 5-9

Springer Publishing Company

Access to resources Recommend Favorite

Design, Synthesis and Biological Evaluation of Novel Tamibarotene Derivative as Multitarget Anticancer Agent

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 8, 2016-08 ,pp. : 729-733

Bentham Science Publishers

Access to resources Recommend Favorite